102 related articles for article (PubMed ID: 1517389)
1. Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation.
Murayama M; Yasuda K; Minamori Y; Mercado-Asis LB; Yamakita N; Miura K
J Clin Endocrinol Metab; 1992 Sep; 75(3):935-42. PubMed ID: 1517389
[TBL] [Abstract][Full Text] [Related]
2. Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation followed by subtotal adrenalectomy.
Murayama M; Yasuda K; Minamori Y; Mercado-Asis LB; Yamakita N; Morita H; Miura K
Tohoku J Exp Med; 1994 Feb; 172(2):97-109. PubMed ID: 8073428
[TBL] [Abstract][Full Text] [Related]
3. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Cushing's disease with reserpine and pituitary irradiation.
Miura K; Aida M; Mihara A; Kato K; Ojima M
J Clin Endocrinol Metab; 1975 Sep; 41(3):511-26. PubMed ID: 1159059
[TBL] [Abstract][Full Text] [Related]
5. [Cushing's disease--pathophysiology and treatment].
Miura K; Torikai T; Yoshinaga K; Sato T
Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67(3):175-202. PubMed ID: 2070889
[TBL] [Abstract][Full Text] [Related]
6. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[TBL] [Abstract][Full Text] [Related]
7. [Study on a new treatment of Cushing's disease with pituitary irradiation and long-term administration of large-dose reserpine (author's transl)].
Miura K
Nihon Naika Gakkai Zasshi; 1974 Jan; 63(1):26-41. PubMed ID: 4856734
[No Abstract] [Full Text] [Related]
8. Effects of reserpine treatment on pituitary-adrenocortical axis in patients with Cushing's disease.
Minamori Y; Yasuda K; Murayama M; Morita H; Yamakita N; Miura K
Endocr J; 1993 Oct; 40(5):545-56. PubMed ID: 7951520
[TBL] [Abstract][Full Text] [Related]
9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
10. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
[TBL] [Abstract][Full Text] [Related]
11. The pituitary ACTH, GH, LH, FSH, TSH and prolactin reserves in patients with Cushing's syndrome.
Hashimoto K
Endocrinol Jpn; 1975 Feb; 22(1):67-77. PubMed ID: 805044
[TBL] [Abstract][Full Text] [Related]
12. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
13. Combined reserpine and pituitary irradiation therapy for Cushing's disease patients following unsuccessful transsphenoidal microsurgery.
Sasaki M; Umeda T; Iwaoka T; Inoue J; Sato T
Endocrinol Jpn; 1990 Aug; 37(4):591-7. PubMed ID: 1964639
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease.
Littley MD; Shalet SM; Beardwell CG; Ahmed SR; Sutton ML
Clin Endocrinol (Oxf); 1990 Oct; 33(4):445-55. PubMed ID: 2225489
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pituitary-dependent Cushing's syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery.
Nagesser SK; van Seters AP; Kievit J; Hermans J; van Dulken H; Krans HM; van de Velde CJ
Clin Endocrinol (Oxf); 2000 Apr; 52(4):427-35. PubMed ID: 10762285
[TBL] [Abstract][Full Text] [Related]
20. Results of treating childhood Cushing's disease with pituitary irradiation.
Jennings AS; Liddle GW; Orth DN
N Engl J Med; 1977 Nov; 297(18):957-62. PubMed ID: 909542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
